If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).




schemaVersion:


SCHEDULE 13D




Comment for Type of Reporting Person:
These 1,396,665 Common Shares under Items (7), (9) and (11) consist of (i) 1,004,900 Common Shares; (ii) 361,765 Common Shares issuable upon exercise of common share purchase warrants (the "Warrants"); and (iii) 30,000 restricted share units (the "RSUs" together with the Warrants, the "Derivative Securities"). Item (13) is calculated based on 10,203,826 Common Shares, consisting of (i) 9,812,061 Common Shares issued and outstanding on May 19, 2026, as reported in the Management's Discussion and Analysis for the second quarter ended March 31, 2026, as furnished by the Issuer to the SEC on Form 6-K on May 20, 2026, plus (i) 361,765 Common Shares issuable to the Reporting Person upon exercise of the Warrants; and (ii) 30,000 Common Shares issuable to the Reporting Person upon settlement of the RSUs.


SCHEDULE 13D


 
Ian McDonald
 
Signature:Ian McDonald
Name/Title:President, Chief Executive Officer and Director of the Issuer
Date:07/02/2026